Dr. Scott Antonia, MD

Claim this profile

Duke University

Studies Lung Cancer
2 reported clinical trials
5 drugs studied

Area of expertise

1

Lung Cancer

Scott Antonia, MD has run 2 trials for Lung Cancer. Some of their research focus areas include:

Stage IV
Stage I
Stage II

Affiliated Hospitals

Image of trial facility.

Duke University

More about Scott Antonia, MD

Clinical Trial Related

3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 0 Active Clinical Trials

Treatments Scott Antonia, MD has experience with

  • Evolocumab
  • Ipilimumab
  • Nivolumab
  • Alirocumab
  • Cemiplimab

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Scott Antonia, MD specialize in?

Is Scott Antonia, MD currently recruiting for clinical trials?

Are there any treatments that Scott Antonia, MD has studied deeply?

What is the best way to schedule an appointment with Scott Antonia, MD?

What is the office address of Scott Antonia, MD?

Is there any support for travel costs?